Schedule 13G ownership disclosure

CLEARMIND MEDICINE INC

Common Shares, no par value per share · CUSIP: 185053402

Event date: 2025-11-19

Filing-level shares
3,307,291.00
Percent of class
9.99%
  • Nissim Daniel

    Shares: 3,307,291.00 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-116091
Form type
SCHEDULE 13G
Filer
Clearmind Medicine Inc.
CIK
CIK 1892500
Filed
Nov 28, 2025
Reporting period
Nov 19, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub